Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Functional definition of NrtR, a remnant regulator of NAD+ homeostasis in the zoonotic pathogen Streptococcus suis.
Wang Q, Hassan BH, Lou N, Merritt J, Feng Y. Wang Q, et al. Among authors: lou n. FASEB J. 2019 May;33(5):6055-6068. doi: 10.1096/fj.201802179RR. Epub 2019 Feb 13. FASEB J. 2019. PMID: 30759348 Free PMC article.
The regulator of this pathway is Nudix-related transcriptional regulator (NrtR), a transcription regulator of the Nudix family comprising an N-terminal Nudix-like effector domain, and a C-terminal DNA-binding winged helix-turn-helix-like domain. ...This control of NAD(+) h …
The regulator of this pathway is Nudix-related transcriptional regulator (NrtR), a transcription regulator of the Nudix family comprising an …
High-Throughput Antigen Microarray Identifies Longitudinal Prognostic Autoantibody for Chemoimmunotherapy in Advanced Non-Small Cell Lung Cancer.
Dai L, Tan Q, Li L, Lou N, Zheng C, Yang J, Huang L, Wang S, Luo R, Fan G, Xie T, Yao J, Zhang Z, Tang L, Shi Y, Han X. Dai L, et al. Among authors: lou n. Mol Cell Proteomics. 2024 Mar 20;23(5):100749. doi: 10.1016/j.mcpro.2024.100749. Online ahead of print. Mol Cell Proteomics. 2024. PMID: 38513890 Free PMC article.
Identification of novel prognostic autoantibodies in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone via a high-throughput antigen microarray.
Dai L, Chen H, Tan Q, Wang Y, Li L, Lou N, Fan G, Xie T, Luo R, Wang S, Zhou Y, Zhong Q, Yao J, Zhang Z, Tang L, Shi Y, Han X. Dai L, et al. Among authors: lou n. Cancer. 2024 Apr 15;130(8):1257-1269. doi: 10.1002/cncr.35158. Epub 2023 Dec 22. Cancer. 2024. PMID: 38133926
157 results